Found: 17
Select item for more details and to access through your institution.
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31328-x
- By:
- Publication type:
- Article
Bacterial Flora in the Gill Tissues and Intestinal Tracts of Male and Female Chinese Mitten Crabs (Eriocheir sinensis) with Different Diets in a Mud Pond.
- Published in:
- Current Microbiology, 2021, v. 78, n. 6, p. 2291, doi. 10.1007/s00284-021-02487-9
- By:
- Publication type:
- Article
Cellulose acetate-promoted polymer-in-salt electrolytes for solid-state lithium batteries.
- Published in:
- Journal of Solid State Electrochemistry, 2023, v. 27, n. 6, p. 1411, doi. 10.1007/s10008-023-05414-z
- By:
- Publication type:
- Article
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-44067-4
- By:
- Publication type:
- Article
Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2).
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02797-8
- By:
- Publication type:
- Article
ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56277-2
- By:
- Publication type:
- Article
Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 5, p. 1, doi. 10.1002/ctm2.835
- By:
- Publication type:
- Article
Natural Selection on Exonic SNPs Shapes Allelic Expression Imbalance (AEI) Adaptability in Lung Cancer Progression.
- Published in:
- Frontiers in Genetics, 2020, v. 11, p. 1, doi. 10.3389/fgene.2020.00665
- By:
- Publication type:
- Article
Revisiting Non-BRCA1/2 Familial Whole Exome Sequencing Datasets Implicates NCK1 as a Cancer Gene.
- Published in:
- Frontiers in Genetics, 2019, p. N.PAG, doi. 10.3389/fgene.2019.00527
- By:
- Publication type:
- Article
Dynamic coupling modelling and application case analysis of high-slip motors and pumping units.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0227827
- By:
- Publication type:
- Article
Fabrication of Hierarchical Assemblies through Temperature‐Triggered Liquid Crystallization Driven Self‐Assembly.
- Published in:
- Small Methods, 2024, v. 8, n. 9, p. 1, doi. 10.1002/smtd.202301525
- By:
- Publication type:
- Article
C/EBPα deficiency in podocytes aggravates podocyte senescence and kidney injury in aging mice.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 10, p. N.PAG, doi. 10.1038/s41419-019-1933-2
- By:
- Publication type:
- Article
Control on the flow performance of inorganic artificial stone powderby compound cement grinding process.
- Published in:
- New Building Materials / Xinxing Jianzhu Cailiao, 2019, v. 46, n. 7, p. 32
- By:
- Publication type:
- Article
Pharmacokinetic/LDL‐C and exposure–response analysis of tafolecimab in Chinese hypercholesterolemia patients: Results from phase I, II, and III studies.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2791, doi. 10.1111/cts.13674
- By:
- Publication type:
- Article
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01359-x
- By:
- Publication type:
- Article
GLT8D2 is a prognostic biomarker and regulator of immune cell infiltration in gastric cancer.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1370367
- By:
- Publication type:
- Article
667-P: IBI362 (LY3305677), a Weekly-Dose Glucagon-Like Peptide-1/Glucagon Receptor Dual Agonist, in Subjects with Overweight or Obesity.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-667-P
- By:
- Publication type:
- Article